Great Point Partners LLC Portfolio Holdings

Great Point Partners LLC

  • $216 Million
  • Q3 2024

Great Point Partners LLC has filed its 13F form on November 13, 2024 for Q3 2024 where it was disclosed a total value porftolio of $216 Million distributed in 30 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Pliant Therapeutics, Inc. with a value of $21.4M, Evolus, Inc. with a value of $19M, Viridian Therapeutics, Inc.\De with a value of $17.1M, Cytokinetics Inc with a value of $16.7M, and Kal Vista Pharmaceuticals, Inc. with a value of $15M.

Examining the 13F form we can see an decrease of $161M in the current position value, from $377M to 216M.

Great Point Partners LLC is based out at Greenwich, CT

Below you can find more details about Great Point Partners LLC portfolio as well as his latest detailed transactions.

Portfolio value $216 Million
Healthcare: $213 Million

Stock Holdings Table Market Cap. of $200 Billions or more

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 30
  • Current Value $216 Million
  • Prior Value $377 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 13, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 5 stocks
  • Additional Purchases 3 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 19 stocks
Track This Portfolio

Track Great Point Partners LLC Portfolio

Follow Great Point Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Point Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email